Items tagged with Guidelines
Latest Union guide for diagnosis and management of TB in children and adolescents launches (post)
9 February 2023: Today, the fourth edition of The Union’s desk guide for diagnosis and management of tuberculosis (TB) in children and adolescents has been published.
Screen for latent TB infection, USPSTF says (post)
The U.S. Preventive Services Task Force (USPSTF) said adults at increased risk for tuberculosis (TB) should still be screened for latent tuberculosis infection (LTBI).
WHO call for expressions of interest: Experts to conduct systematic reviews of the evidence on TB and undernutrition (post)
27 June 2023 | Geneva: WHO's Global Tuberculosis Programme has initiated a process to review the evidence on TB and nutrition to update the previous WHO guidelines: Nutritional care and support for patients with tuberculosis.
Experts identify clinical standards for adverse effects to TB treatment (post)
A panel of 65 global experts have identified eight clinical standards for the management of adverse effects during treatment for tuberculosis (TB).
Global prison TB surge exposes WHO guidelines gap (post)
Despite increasing TB rates in prisons across the globe, current World Health Organization (WHO) TB prevention guidelines fail to reach incarcerated populations. Programs should instead prioritize them, argue a group of researchers from a range of global institutions.
New operational guidance on adaptation and implementation of WHO's Multisectoral Accountability Framework to end TB (post)
20 September 2023 | New York The World Health Organization (WHO) has released Operational guidance for countries to support the adaptation and implementation of the Multisectoral Accountability Framework to end TB (MAF-TB). It provides practical advice on key approaches and interventions needed to establish the MAF-TB at the national and local levels with concrete country examples and best practices.
Standards for clinical trials for treating TB (post)
The value, speed of completion and robustness of the evidence generated by TB treatment clinical trials could be improved by implementing standards for best practice.
WHO announces forthcoming updates on co-administration of treatment for drug-resistant TB and hepatitis C (post)
9 April 2024 — In a Rapid Communication issued today, the World Health Organization (WHO) is announcing updates on co-administration of treatment for drug-resistant tuberculosis and hepatitis C (HCV). The evidence suggests that concomitant treatment for HCV and multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB) is feasible, with potential benefits outweighing the harms. Co-administration may increase MDR/RR-TB treatment success and reduce failures, losses to follow-up, and deaths. Adherence support for HCV treatment during MDR/RR-TB treatment is also acknowledged.
South African National Tuberculosis Management Guidelines (document)
The guidelines formally introduce targeted screening to increase detection of TB cases, guidance for the use of GeneXpert and revised treatment regimens for retreatment patients. The 120-document also includes guidance on the management of adverse drug events and antiretroviral initiation for patients co-infected with HIV.
Guidelines for the management of tuberculosis in children (document)
The guidelines outline care and treatment for children with tuberculosis (TB) in South Africa, include better guidance on dosing children with TB in the absence of widely available paediatric formulations including changes to the recommended doses for some drugs and sections on TB diagnosis in HIV-infected children, TB preventative treatment and nutritional support.
Page 9 of 16 · Total posts: 0
←First 8 9 10 Last→